Age, Biography and Wiki
Marsha Moses was born on 1953 in Boston, is an American physician and academic. Discover Marsha Moses's Biography, Age, Height, Physical Stats, Dating/Affairs, Family and career updates. Learn How rich is she in this year and how she spends money? Also learn how she earned most of networth at the age of 71 years old?
| Popular As |
N/A |
| Occupation |
N/A |
| Age |
71 years old |
| Zodiac Sign |
N/A |
| Born |
|
| Birthday |
|
| Birthplace |
Boston |
| Nationality |
|
We recommend you to check the complete list of Famous People born on .
She is a member of famous Physician with the age 71 years old group.
Marsha Moses Height, Weight & Measurements
At 71 years old, Marsha Moses height not available right now. We will update Marsha Moses's Height, weight, Body Measurements, Eye Color, Hair Color, Shoe & Dress size soon as possible.
| Physical Status |
| Height |
Not Available |
| Weight |
Not Available |
| Body Measurements |
Not Available |
| Eye Color |
Not Available |
| Hair Color |
Not Available |
Dating & Relationship status
She is currently single. She is not dating anyone. We don't have much information about She's past relationship and any previous engaged. According to our Database, She has no children.
| Family |
| Parents |
Not Available |
| Husband |
Not Available |
| Sibling |
Not Available |
| Children |
Not Available |
Marsha Moses Net Worth
Her net worth has been growing significantly in 2023-2024. So, how much is Marsha Moses worth at the age of 71 years old? Marsha Moses’s income source is mostly from being a successful Physician. She is from . We have estimated Marsha Moses's net worth, money, salary, income, and assets.
| Net Worth in 2024 |
$1 Million - $5 Million |
| Salary in 2024 |
Under Review |
| Net Worth in 2023 |
Pending |
| Salary in 2023 |
Under Review |
| House |
Not Available |
| Cars |
Not Available |
| Source of Income |
Physician |
Marsha Moses Social Network
| Instagram |
|
| Linkedin |
|
| Twitter |
|
| Facebook |
|
| Wikipedia |
|
| Imdb |
|
Timeline
Marsha A. Moses is an American physician who is the Julia Dyckman Andrus Professor at Harvard Medical School and the Director of the Vascular Biology Program at Boston Children's Hospital.
Her research considers the biochemical mechanisms that are responsible for tumor growth and progression.
She is a Fellow of the American Institute for Medical and Biological Engineering, the American Academy of Arts and Sciences and the American Association for the Advancement of Science.
Moses was born in Boston.
She was an undergraduate student at Stonehill College, graduating in 1975.
Moses earned a doctorate at Boston University.
Her research considered control of the phosphodiesterase by an endogenous modulator in the prostate.
Moses studies the mechanisms that underpin angiogenesis during tumor progression.
Angiogenesis describes the process by which tumors recruit their own blood vessels.
In the absence of angiogenesis, tumors remain dormant, but can become active and grow if they are influenced by certain genes.
Moses has investigated what regulates these cancer-promoting genes, and the molecular-level differences between dormant and active tumors.
She focused on triple-negative breast cancer, cells of which release extracellular vesicles that cross the blood–brain barrier and promote brain metastases.
Moses demonstrated that obesity could cause tumors that were previously dormant to restart angiogenesis.
She has shown that a tumor-specific CRISPR gene editing system could be used to stop the growth of triple-negative breast cancer.
Moses has developed multiple tools for theranostics; apparatus capable of both diagnostics and therapeutics.
She has identified several inhibitors of tumor formation that function at the transcriptional and translational level.
Moses created initiatives focused on proteomics and biomarker discovery at Boston Children's Hospital.
Her urinary proteomics initiative realized sensitive, specific, non-invasive tests for cancer.
She developed a human sample repository to uncover non-invasive biomarkers for human cancers.
